Spineway (ALSPW) - Total Liabilities

Latest as of December 2025: €6.40 Million EUR ≈ $7.49 Million USD

Based on the latest financial reports, Spineway (ALSPW) has total liabilities worth €6.40 Million EUR (≈ $7.49 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ALSPW strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Spineway - Total Liabilities Trend (2009–2025)

This chart illustrates how Spineway's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Spineway's balance sheet.

Spineway Competitors by Total Liabilities

The table below lists competitors of Spineway ranked by their total liabilities.

Company Country Total Liabilities
PURE ENERGY MINLS
F:AHG
Germany €249.45K
Future Consumer Limited
NSE:FCONSUMER
India Rs8.53 Billion
JPMorgan Asia Growth & Income plc
LSE:JAGI
UK GBX4.40 Million
H3 Energy Limited
AU:H3E
Australia AU$4.89 Million
Helios Energy Ltd
AU:HE8
Australia AU$1.91 Million
MRG Metals Ltd
AU:MRQ
Australia AU$182.35K
Mask Investments Limited
NSE:MASKINVEST
India Rs8.14 Million

Liability Composition Analysis (2009–2025)

This chart breaks down Spineway's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Spineway to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.88 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Spineway's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Spineway (2009–2025)

The table below shows the annual total liabilities of Spineway from 2009 to 2025.

Year Total Liabilities Change
2025-12-31 €6.40 Million
≈ $7.49 Million
+3.88%
2024-12-31 €6.17 Million
≈ $7.21 Million
-15.05%
2023-12-31 €7.26 Million
≈ $8.48 Million
+27.58%
2022-12-31 €5.69 Million
≈ $6.65 Million
+21.31%
2021-12-31 €4.69 Million
≈ $5.48 Million
-0.87%
2020-12-31 €4.73 Million
≈ $5.53 Million
-24.69%
2019-12-31 €6.28 Million
≈ $7.34 Million
-3.16%
2018-12-31 €6.49 Million
≈ $7.58 Million
-20.31%
2017-12-31 €8.14 Million
≈ $9.52 Million
-0.13%
2016-12-31 €8.15 Million
≈ $9.53 Million
+37.19%
2015-12-31 €5.94 Million
≈ $6.95 Million
-10.22%
2014-12-31 €6.62 Million
≈ $7.74 Million
+58.25%
2013-12-31 €4.18 Million
≈ $4.89 Million
+11.67%
2012-12-31 €3.74 Million
≈ $4.38 Million
+29.12%
2011-12-31 €2.90 Million
≈ $3.39 Million
+45.87%
2010-12-31 €1.99 Million
≈ $2.32 Million
+23.56%
2009-12-31 €1.61 Million
≈ $1.88 Million
--

About Spineway

PA:ALSPW France Medical Instruments & Supplies
Market Cap
$4.95 Million
€4.23 Million EUR
Market Cap Rank
#28777 Global
#515 in France
Share Price
€0.12
Change (1 day)
-0.83%
52-Week Range
€0.12 - €0.23
All Time High
€1000000.00
About

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more